8279 Stock Overview
Engages in the research, development, manufacturing, and sale of microbial pharmaceutical raw materials, biological pesticides, fertilizers and biochemical nutritional products, and preventive medicine. More details
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 2/6 |
Financial Health | 6/6 |
Dividends | 3/6 |
Rewards
Risk Analysis
No risks detected for 8279 from our risk checks.
Syngen Biotech Co.,Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | NT$131.00 |
52 Week High | NT$163.50 |
52 Week Low | NT$127.00 |
Beta | 0.43 |
11 Month Change | -1.50% |
3 Month Change | -6.09% |
1 Year Change | -14.94% |
33 Year Change | 23.00% |
5 Year Change | 10.55% |
Change since IPO | 1,228.11% |
Recent News & Updates
Recent updates
Does Syngen BiotechLtd (GTSM:8279) Have A Healthy Balance Sheet?
Mar 25Should Syngen Biotech Co., Ltd. (GTSM:8279) Be Part Of Your Dividend Portfolio?
Feb 25Did You Miss Syngen Biotech's (GTSM:8279) Impressive 104% Share Price Gain?
Feb 04Is Syngen Biotech Co., Ltd.'s (GTSM:8279) Latest Stock Performance Being Led By Its Strong Fundamentals?
Jan 14Syngen Biotech (GTSM:8279) Seems To Use Debt Quite Sensibly
Dec 16Syngen Biotech's (GTSM:8279) Earnings Are Growing But Is There More To The Story?
Nov 25Shareholder Returns
8279 | TW Pharmaceuticals | TW Market | |
---|---|---|---|
7D | 0.8% | 1.4% | 0.8% |
1Y | -14.9% | 7.5% | 30.3% |
Return vs Industry: 8279 underperformed the TW Pharmaceuticals industry which returned 7.5% over the past year.
Return vs Market: 8279 underperformed the TW Market which returned 30.3% over the past year.
Price Volatility
8279 volatility | |
---|---|
8279 Average Weekly Movement | 3.1% |
Pharmaceuticals Industry Average Movement | 3.6% |
Market Average Movement | 4.6% |
10% most volatile stocks in TW Market | 8.0% |
10% least volatile stocks in TW Market | 2.1% |
Stable Share Price: 8279 has not had significant price volatility in the past 3 months compared to the TW market.
Volatility Over Time: 8279's weekly volatility (3%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1988 | n/a | Wei Chen | www.syngen.com.tw |
Syngen Biotech Co.,Ltd. engages in the research, development, manufacturing, and sale of microbial pharmaceutical raw materials, biological pesticides, fertilizers and biochemical nutritional products, and preventive medicine. It also offers contract manufacturing; science-based and bio active pharmaceutical ingredients; and private labelling.
Syngen Biotech Co.,Ltd. Fundamentals Summary
8279 fundamental statistics | |
---|---|
Market cap | NT$3.55b |
Earnings (TTM) | NT$238.77m |
Revenue (TTM) | NT$2.00b |
14.9x
P/E Ratio1.8x
P/S RatioIs 8279 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
8279 income statement (TTM) | |
---|---|
Revenue | NT$2.00b |
Cost of Revenue | NT$1.29b |
Gross Profit | NT$707.90m |
Other Expenses | NT$469.13m |
Earnings | NT$238.77m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 8.81 |
Gross Margin | 35.39% |
Net Profit Margin | 11.94% |
Debt/Equity Ratio | 10.9% |
How did 8279 perform over the long term?
See historical performance and comparison